Revvity, Inc. (LON:0KHE)

Market Cap	8.40B -31.6%
Revenue (ttm)	2.12B +3.7%
Net Income	178.86M -10.8%
EPS	1.53 -5.8%
Shares Out	n/a
PE Ratio	46.97
Forward PE	18.93
Dividend	0.21 (0.20%)
Ex-Dividend Date	Jan 16, 2026

Volume	404
Average Volume	187
Open	100.47
Previous Close	102.38
Day's Range	94.14 - 100.47
52-Week Range	81.44 - 120.14
Beta	1.09
RSI	44.17
Earnings Date	Feb 2, 2026

About Revvity

Revvity, Inc. provides health sciences solutions, technologies, and services. The company provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and DNA sequencing services; and instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and dise...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 1937
• Employees: 11,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0KHE

Financial Performance

In 2025, Revvity's revenue was $2.86 billion, an increase of 3.67% compared to the previous year's $2.76 billion. Earnings were $241.20 million, a decrease of -10.79%.

Financial numbers in USD